Breaking News

ChanTest Opens Expanded Lab Facilities

Adds 50% more capacity for cell and molecular biology services

By: Kristin Brooks

Managing Editor, Contract Pharma

ChanTest Corp. has expanded capacity by more than 50% for its cellular and molecular services and reagents for drug research at its headquarters in Cleveland, OH. ChanTest scientists use the cells grown in the new facility for ion channel services and products, and for external clients outsourcing cell and molecular work. Examples include standard cell culture services and highly technical custom cell line development projects.
 
ChanTest’s director of Cell & Molecular Biology, Luke Armstrong, Ph.D., said, “Our cell and molecular biology service business nearly doubled in 2013 and we expect another year of strong growth in 2014,” said Dr. Armstrong. “The expansion helps ChanTest keep up with the growing needs of our clients.”
 
The new space is fully operational and used for: cell culture labs, adherent cell scale-up of 10 billion cells, controlled rate freezer capable of cryopreserving 600 vials of cells, membrane preparations of up to 2 grams of protein, large-scale electroporator capable of generating three billion transfected cells, flow sorter (FACSAria), dedicated molecular biology lab, and radioisotope lab.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters